RecallDepth
Class III Terminated

Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters packaged in a carton (NDC 0054-0097-20) and b) 100-count bottle (NDC 0054-0097-25), Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216

This recall has been terminated (originally issued December 18, 2013).

Company
Boehringer Ingelheim Roxane Inc
Recall Initiated
March 18, 2013
Posted
December 18, 2013
Recall Number
D-343-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
8,550 cartons and bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

SubPotent Drug: The firm discovered out of specification results for assay and the extended investigation revealed the potential for lower weight tablets.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) 259666A, Exp. MAR 2014; b) 259666B, Exp. MAR 2014

More recalls by Boehringer Ingelheim Roxane Inc

View all recalls by this company →

Other recent Class III Drug recalls